Comments on: REMS and Generics — Like Oil and Water http://crossborderbiotech.ca/2009/06/27/rems-and-generics-like-oil-and-water/ Biotechnology, Health and Business in Canada, the United States and Worldwide Mon, 02 Apr 2012 12:31:04 +0000 hourly 1 http://wordpress.com/ By: Dreaming of REMS: A Second Reason Why FDAAA Risk Evaluation and Mitigation Strategies Might Be a Benefit to Drug Developers « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2009/06/27/rems-and-generics-like-oil-and-water/comment-page-1/#comment-1038 Mon, 19 Oct 2009 20:26:10 +0000 http://crossborderbiotech.ca/?p=2416#comment-1038 [...] previously noted by Michael and discussed here, limiting generic competition for off-patent drugs (REMS don’t die or fade away, they just [...]

]]>